Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

They offer investors very different value propositions.

Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...

Apple Watch displays real-time glucose data from CGM devices like the Dexcom G7, while Apple continues to develop ...

See how 2026 ADA guidance broadens CGM use beyond insulin, urges payer coverage, and highlights kids, pregnancy, and older ...

The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five ...

Total healthcare costs were significantly lower among adults with diabetes who used continuous glucose monitoring (CGM) systems compared to those who did not use CGM, according to a December study ...

In 1999, the U.S. Food and Drug Administration approved continuous glucose monitoring (CGM), a medical device that uses a ...

DexCom has barely scratched the surface of its niche in the diabetes market. As a result of industry challenges, the stock's valuation has now come down. But from here, the stock looks well-positioned ...

In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...